News & Events

Nov 28, 2018

ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes

Read More

Sep 27, 2018

ViaCyte to Present at Investor, Partnering, and Scientific Conferences in October

Read More

Sep 25, 2018

Gore Strengthens Collaborative Relationship with ViaCyte by Investing Additional $10 Million

Read More

Sep 17, 2018

CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes

Read More

Jun 23, 2018

Two-year Data from ViaCyte’s STEP ONE Clinical Trial Presented at ADA 2018

Read More

May 25, 2018

ViaCyte to Present at the American Diabetes Association’s 78th Scientific Sessions

Read More

Apr 17, 2018

ViaCyte Awarded NIH SBIR Grant to Support In Vitro Development of Stem Cell-Derived Functional Human Pancreatic Beta Cells

Read More

Apr 17, 2018

ViaCyte Substantially Expands Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications

Read More

Apr 12, 2018

ViaCyte to Present at Alliance for Regenerative Medicine’s 6th Annual Cell & Gene Therapy Investor Day in New York City

Read More

Jan 19, 2018

ViaCyte to Present at Three Upcoming Healthcare Events

Read More

Jan 05, 2018

ViaCyte Announces First Patients Implanted in Cohort 2 with Potentially Efficacious Dose of PEC-Direct Islet Cell Replacement Therapy

Read More